Every conference I attend has at least three sessions on AI in pharmacy. Most of them are vendor pitches dressed up as education. The reality is more nuanced: some AI applications in pharmacy are delivering measurable value today, others are promising but unproven, and a few are solutions looking for problems that do not exist. Here is an honest assessment.
What Is Working Now
Prescription volume forecasting is the most mature AI application in pharmacy operations. Machine learning models that predict fill volume by day, by drug category, and by site are accurate enough to drive staffing decisions and inventory purchasing. These are not theoretical — they are running in production at health systems and large pharmacy chains, and early adopters report measurable reductions in labor waste compared to historical-average staffing models.
Prior authorization automation is the second area with real traction. AI systems that read PA requirements, pull relevant clinical data from the EHR, and pre-populate PA forms are cutting manual processing time significantly. The AMA's 2024 physician survey found practices spend an average of 13 hours per week on prior authorizations across roughly 39 requests — about 20 minutes each. AI-assisted PA tools aim to eliminate most of that manual effort, though published ROI data from pharmacy-specific deployments remains limited.
Medication therapy management targeting is the third. Instead of reviewing every patient for MTM eligibility manually, AI models score patients by likelihood of benefit — based on polypharmacy, adherence gaps, disease complexity, and payer incentives. The pharmacist's time goes to the patients who will benefit most, not to a random sample.
What Is Promising but Unproven
Inventory optimization beyond basic par-level management is in the promising-but-early category. AI systems that predict short-dated risk, suggest therapeutic substitutions to reduce carrying cost, and optimize wholesaler order timing are being piloted but have not yet demonstrated consistent ROI across different pharmacy settings. The problem is data quality — most pharmacy management systems do not capture the granular inventory movement data these models need to train effectively.
Clinical decision support that goes beyond drug-drug interaction checking is also early. Models that flag high-risk medication regimens, predict adverse events, or suggest deprescribing candidates are in development at academic medical centers but have not crossed into community or FQHC pharmacy practice in a meaningful way.
What Is Still Hype
Fully autonomous dispensing — the idea that AI will replace the pharmacist's clinical judgment in the verification and counseling process — is not close. The regulatory framework does not support it, the liability model does not support it, and the technology is not reliable enough for the consequence of error. Anyone selling you this vision is selling a future that is at least a decade away.
Chatbot-based patient communication is another area where the promise exceeds the delivery. Patients with complex medication questions do not want to talk to a chatbot. They want to talk to their pharmacist. AI can handle refill reminders, appointment scheduling, and simple FAQ responses. It cannot replace the therapeutic relationship.
How to Evaluate AI Vendors
When a vendor tells you their AI will transform your pharmacy, ask three questions. First, what specific metric will improve and by how much — not a range, a number with a methodology behind it. Second, what data do they need from your systems and who is responsible for the integration. Third, can they provide a reference from an organization similar to yours in size, patient population, and pharmacy model. If they cannot answer all three clearly, the product is not ready for your operation.
AI in pharmacy is real and getting more useful every year. But the organizations that benefit are the ones that start with a clear operational problem and look for AI that solves it — not the ones that buy AI and then look for a problem to apply it to.